DQ EXOCELL +PDRN in Pakistan: Exosome Serum Evidence Guide
The NEES catalogue lists DQ EXOCELL +PDRN, while Dermaqual's current product is named DQ XOCELL: a one-vial 10 ml topical serum listing Cica-derived exosomes, PDRN, hyaluronic acid, panthenol and plant callus material.
Exosome skincare is an emerging category with heterogeneous early evidence and important source, characterization, sterility and regulatory questions; the manufacturer listing is not equivalent to independent proof of clinical benefit.
Catalogue visual: DQ EXOCELL +PDRN | High-Potency Exosome Serum (1 x 10ml) from the NEES Medical product catalogue. Packaging appearance alone does not establish authenticity; verify the supplied batch, expiry, seals and traceability documents.
What it is
Dermaqual states that DQ XOCELL contains 8.5 billion Cica exosomes, 11 microRNAs, PDRN, high-molecular-weight hyaluronic acid, nucleic acids, amino acids, panthenol and plant callus stem cell material. It lists topical application to face, neck or body. The term exosome has a precise scientific meaning, but public product pages rarely provide the isolation, characterization and batch-release data used in extracellular-vesicle research. Clinics should therefore obtain technical documentation and should not describe this topical cosmetic as an approved regenerative biologic.
Market position and alternatives
DQ XOCELL competes in premium post-procedure and rejuvenation skincare, where 'exosome' products vary substantially in source and evidence.
| Option | Positioning | Major distinction |
|---|---|---|
| DQ XOCELL / EXOCELL | Cica-exosome and PDRN topical serum | Plant-derived positioning; technical characterization should be requested |
| Conventional HA and panthenol serum | Barrier support and hydration | More familiar ingredients without an exosome claim |
| Growth-factor or conditioned-media skincare | Signalling-protein cosmeceutical | Different biological source, quality controls and evidence |
| Exosome product used invasively | Off-label or regulated-biologic territory | Distinct risk and regulatory scrutiny; not supported by this topical label |
Potential advantages
- The manufacturer identifies the claimed exosome source as Cica and states a particle count.
- The formula also contains established cosmetic humectant and barrier-support ingredients such as hyaluronic acid and panthenol.
- The single 10 ml vial simplifies pack verification and lot tracking.
- The current official route is topical, allowing the product to be distinguished from invasive exosome procedures.
Limitations and buying considerations
- No independent clinical trial of DQ XOCELL was found in the reviewed sources.
- The public page does not provide extracellular-vesicle characterization, purity, potency or release-testing data.
- Research on other exosome sources and formulations cannot prove this product's performance.
- Regulators have warned about unapproved exosome products used to treat conditions, especially invasive uses; this topical product must not be promoted as disease treatment.
Quality and authenticity checklist
- Reconcile the NEES name DQ EXOCELL with the Dermaqual name DQ XOCELL on the physical stock.
- Request current technical documentation covering source, particle characterization, microbiological controls and storage.
- Check the one-by-10 ml presentation, intact seal, batch and expiry against the current official listing.
- Reject stock with unclear origin, loose vials or instructions suggesting an unverified invasive route.
Price and availability in Pakistan
The current DQ EXOCELL +PDRN price in Pakistan is available by quotation from NEES Medical; the live catalogue contains no verified numeric PKR price. The quote should identify whether the supplied label says DQ XOCELL, the one-by-10 ml pack, current expiry and storage conditions.
Clinical safety: Use only by the current labelled topical route; invasive exosome use and disease-treatment claims require separate regulatory and clinical evidence and assessment by a qualified, licensed clinician. Direct all patient-specific, prescribing, procedural and administration questions to an appropriately qualified, licensed healthcare professional.
Sources and further reading
- Dermaqual — DQ XOCELL
- FDA Public Safety Notification on Exosome Products
- Clinical Applications of Exosomes in Cosmetic Dermatology
View the DQ EXOCELL +PDRN | High-Potency Exosome Serum (1 x 10ml) catalogue page or request current pricing and availability.
Frequently Asked Questions
Are DQ EXOCELL and DQ XOCELL the same product?
The catalogue and current manufacturer use different spellings, and the ingredient and one-by-10 ml descriptions appear to align. Confirm the exact physical pack and manufacturer documentation rather than assuming equivalence.
What is its price in Pakistan?
NEES Medical provides the current PKR price by quotation; no numeric live-catalogue price is verified.
Is DQ XOCELL injected?
Dermaqual's current page states topical application. Do not infer an injectable route from sterile packaging or exosome terminology.
Are exosome skincare results guaranteed?
No. Human evidence is early and heterogeneous, and independent DQ XOCELL outcome data were not found.
How is authenticity checked?
Confirm the exact XOCELL/EXOCELL naming, one 10 ml vial, seal, lot, expiry and supplier invoice. Clinics should also request technical quality data for the claimed extracellular vesicles.
How should the vial be stored?
Follow the temperature and light instructions printed on the current carton and technical sheet. Do not invent a storage range when the public listing does not state one.
About NEES Medical
Latest Posts
